When there is an increased level of C4 in the blood test results, then this is generally an indication that there is inflammation happening somewhere within the body. This may be acute or chronic in nature. Increased complement activity may also be an indication of certain cancers, such as leukemia or Hodgkin’s lymphoma.
A low level of C4 is associated with autoimmune diseases, such as lupus and rheumatoid arthritis. Higher-than-normal complement C4 values may be a sign of cancer, ulcerative colitis, and inflammation
Normal ranges for C4 is 15 to 45 milligrams per deciliter (mg/dL) (0.15 to 0.45 g/L).
Test result interpretation
The C4 (complement 4) test measures the level of complement component C4 in the blood. Complement proteins are part of the immune system and play a crucial role in inflammation, immune response, and defense against pathogens. Here's how to interpret the results of a C4 test:
Normal Range:
The normal range for C4 levels in the blood can vary depending on the laboratory and the specific assay used.
Typically, normal values fall within the range of 10 to 40 milligrams per deciliter (mg/dL) or 0.1 to 0.4 grams per liter (g/L).
Interpretation:
Low C4 Levels:
Low C4 levels may indicate complement deficiency, which can be congenital (present at birth) or acquired.
Congenital complement deficiencies are rare genetic disorders that can predispose individuals to recurrent infections, autoimmune diseases, and inflammatory conditions.
Acquired complement deficiencies may occur due to conditions such as autoimmune diseases (e.g., systemic lupus erythematosus), kidney diseases (e.g., lupus nephritis), liver diseases, or certain medications (e.g., corticosteroids).
Clinical Correlation:
Interpretation of C4 levels should be done in conjunction with the patient's clinical history, symptoms, and other laboratory tests.
Additional diagnostic tests, such as complement functional assays or genetic testing, may be necessary to confirm complement deficiency and identify the underlying cause.
Treatment and Management:
Management of low C4 levels depends on the underlying cause and clinical context.
Treatment may involve addressing the underlying condition (e.g., treating autoimmune diseases with immunosuppressive medications), managing infections promptly, and, in some cases, supplementing with intravenous immunoglobulin (IVIG) or other replacement therapies.
High C4 Levels:
High C4 levels are less common and may be seen in conditions associated with increased complement activation, such as acute inflammation, infections, or autoimmune diseases.
However, isolated high C4 levels without other clinical or laboratory abnormalities are uncommon and may require further evaluation to determine the underlying cause.
Follow-Up:
Patients with abnormal C4 levels may require monitoring over time to assess response to treatment and disease activity.
Serial measurement of C4 levels may be necessary to monitor complement activity and guide treatment decisions.
Interpretation of C4 test results should be performed by healthcare professionals experienced in immunology and laboratory medicine. Treatment decisions should be individualized based on the patient's specific clinical circumstances, underlying conditions, and response to therapy. Further evaluation and management may be necessary in cases of abnormal C4 levels to optimize patient care and outcomes.